Subject(s)

CD56 Antigen/analysis , Epstein-Barr Virus Infections/pathology , Eyelid Neoplasms/pathology , Herpesvirus 4, Human/isolation & purification , Killer Cells, Natural/pathology , Lymphoma, Non-Hodgkin/pathology , Lymphoma, T-Cell, Cutaneous/pathology , Skin Neoplasms/pathology , Skin/pathology , T-Lymphocyte Subsets/pathology , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Connective Tissue Diseases/diagnosis , Cyclophosphamide/administration & dosage , Diagnostic Errors , Doxorubicin/administration & dosage , Epstein-Barr Virus Infections/diagnosis , Epstein-Barr Virus Infections/drug therapy , Fatal Outcome , Female , Humans , Immunophenotyping , Killer Cells, Natural/chemistry , Lymphoma, Non-Hodgkin/diagnosis , Lymphoma, Non-Hodgkin/drug therapy , Lymphoma, Non-Hodgkin/virology , Lymphoma, T-Cell, Cutaneous/diagnosis , Lymphoma, T-Cell, Cutaneous/drug therapy , Lymphoma, T-Cell, Cutaneous/virology , Male , Nose , Prednisolone/administration & dosage , Skin Neoplasms/diagnosis , Skin Neoplasms/drug therapy , Skin Neoplasms/virology , T-Lymphocyte Subsets/chemistry , T-Lymphocyte Subsets/virology , Vincristine/administration & dosage , Young Adult